Safe use of Interleukin-17 Inhibitors for Psoriasis and Psoriatic Arthritis in Two Patients with a History of Lymphoproliferative Disease. (2020). SKIN The Journal of Cutaneous Medicine, 4(3), 256-259. https://doi.org/10.25251/skin.4.3.7